Literature DB >> 8694104

Treatment of persistent glaucoma secondary to periocular corticosteroids.

L Akduman1, A E Kolker, D L Black, L V Del Priore, H J Kaplan.   

Abstract

PURPOSE: To describe two patients with uveitis who developed increased intraocular pressure that was unresponsive to maximum medical therapy eight and 13 months after periocular injection of triamcinolone acetonide.
METHODS: Excised periocular tissue was analyzed for corticosteroid activity by gas chromatography and mass spectrometry.
RESULTS: Excision of the periocular tissue, which contained visible triamcinolone acetonide, resulted in a normal intraocular pressure within 14 days in both patients. Analysis of the excised tissue disclosed residual corticosteroid in one of the two patients.
CONCLUSION: Removal of periocular tissue containing injected corticosteroids may facilitate the management of patients developing increased intraocular pressure unresponsive to maximum medical therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8694104     DOI: 10.1016/s0002-9394(14)72027-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

Review 1.  Immunosuppression in uveitis therapy.

Authors:  R N Van Gelder; H J Kaplan
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Orbital steroid injections.

Authors:  R A Goldberg
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

Review 3.  Corticosteroids and glaucoma risk.

Authors:  R C Tripathi; S K Parapuram; B J Tripathi; Y Zhong; K V Chalam
Journal:  Drugs Aging       Date:  1999-12       Impact factor: 3.923

4.  Local corticosteroid treatment of eyelid and orbital xanthogranuloma.

Authors:  Victor M Elner; Roni Mintz; Hakan Demirci; Adam S Hassan
Journal:  Trans Am Ophthalmol Soc       Date:  2005

Review 5.  Ocular side effects of anti-rheumatic medications: what a rheumatologist should know.

Authors:  V Peponis; V C Kyttaris; S E Chalkiadakis; S Bonovas; N M Sitaras
Journal:  Lupus       Date:  2010-02-09       Impact factor: 2.911

6.  Intracameral dexamethasone reduces inflammation on the first postoperative day after cataract surgery in eyes with and without glaucoma.

Authors:  Diane T W Chang; Michael C Herceg; Richard A Bilonick; Larissa Camejo; Joel S Schuman; Robert J Noecker
Journal:  Clin Ophthalmol       Date:  2009-06-02

7.  Periocular corticosteroid injections in uveitis: effects and complications.

Authors:  H Nida Sen; Susan Vitale; Sapna S Gangaputra; Robert B Nussenblatt; Teresa L Liesegang; Grace A Levy-Clarke; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; John H Kempen
Journal:  Ophthalmology       Date:  2014-07-11       Impact factor: 12.079

Review 8.  Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.

Authors:  Sherif A Gaballa; Uday B Kompella; Omar Elgarhy; Ali M Alqahtani; Barbara Pierscionek; Raid G Alany; Hamdy Abdelkader
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

9.  Intraocular pressure elevation after subtenon triamcinolone acetonide injection; Multicentre retrospective cohort study in Japan.

Authors:  Yuki Maeda; Hiroto Ishikawa; Hiroki Nishikawa; Miho Shimizu; Takamasa Kinoshita; Rie Ogihara; Shigehiko Kitano; Chihiro Yamanaka; Yoshinori Mitamura; Masahiko Sugimoto; Mineo Kondo; Yoshihiro Takamura; Nahoko Ogata; Tomohiro Ikeda; Fumi Gomi
Journal:  PLoS One       Date:  2019-12-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.